litlas
Log inCreate account

David S. Celermajer

Active 1984–2025

Also published as
David S Celermajer
265
Papers
60,574
Citations
118
h-index
247
i10-index

Citations

Citations per year for David S. Celermajer1951: 1 citations1956: 2 citations1964: 1 citations1966: 1 citations1972: 1 citations1978: 1 citations1980: 1 citations1985: 2 citations1986: 1 citations1988: 2 citations1989: 4 citations1990: 1 citations1991: 1 citations1992: 3 citations1993: 8 citations1994: 21 citations1995: 38 citations1996: 88 citations1997: 193 citations1998: 209 citations1999: 221 citations2000: 376 citations2001: 368 citations2002: 358 citations2003: 420 citations2004: 423 citations2005: 388 citations2006: 390 citations2007: 347 citations2008: 392 citations2009: 367 citations2010: 397 citations2011: 358 citations2012: 415 citations2013: 372 citations2014: 334 citations2015: 343 citations2016: 351 citations2017: 271 citations2018: 268 citations2019: 1,190 citations2020: 1,504 citations2021: 1,279 citations2022: 1,120 citations2023: 757 citations2024: 1,175 citations2025: 506 citations2026: 20 citations1952–1955: no citations, so these years are not shown1957–1963: no citations, so these years are not shown1965: no citations, so this year is not shown1967–1971: no citations, so these years are not shown1973–1977: no citations, so these years are not shown1979: no citations, so this year is not shown1981–1984: no citations, so these years are not shown1987: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,599 citing papers, 23.6% of this breakdownUnited Kingdom: 1,662 citing papers, 8.5% of this breakdownAustralia: 1,152 citing papers, 5.9% of this breakdownGermany: 1,046 citing papers, 5.4% of this breakdownChina: 1,022 citing papers, 5.2% of this breakdownItaly: 1,008 citing papers, 5.2% of this breakdownCanada: 888 citing papers, 4.6% of this breakdownFrance: 790 citing papers, 4.1% of this breakdownNetherlands: 670 citing papers, 3.4% of this breakdownJapan: 488 citing papers, 2.5% of this breakdownSpain: 454 citing papers, 2.3% of this breakdownSwitzerland: 426 citing papers, 2.2% of this breakdown
0%23.6%Other 27.1%

Institutions

Fields

  • Medicine82.2%
  • Biochemistry, Genetics and Molecular Biology8.5%
  • Immunology and Microbiology2.1%
  • Neuroscience1.7%
  • Engineering1.3%
  • Nursing1.1%
  • Other3.1%

Topics

  • Pulmonary Hypertension Research and Treatments6.3%
  • Cardiovascular Health and Disease Prevention5%
  • Cardiovascular Function and Risk Factors3.2%
  • Congenital Heart Disease Studies3.1%
  • Nitric Oxide and Endothelin Effects2.4%
  • Cardiac Valve Diseases and Treatments1.9%
  • Other78.1%

Coauthors

All papers

Open in search
  1. Haemodynamic definitions and updated clinical classification of pulmonary hypertension

    Authors: Gérald Simonneau, David Montani, David S. Celermajer, Christopher P. Denton, Michael Α. Gatzoulis, Michael J. Krowka, Paul Williams, Rogério Souza - European Respiratory Journal 2018 cited by 3,806

  2. Evaluation and Management of the Child and Adult With Fontan Circulation: A Scientific Statement From the American Heart Association

    Authors: Jack Rychik, Andrew M. Atz, David S. Celermajer, Barbara J. Deal, Michael Α. Gatzoulis, Marc Gewillig, Tain‐Yen Hsia, Daphne T. Hsu, Adrienne H. Kovacs, Brian W. McCrindle, Jane W. Newburger, Nancy A. Pike, Mark D. Rodefeld, David N. Rosenthal, Kurt R. Schumacher, Bradley S. Marino, Karen Stout, Gruschen Veldtman, Adel K. Younoszai, Yves d’Udekem - Circulation 2019 cited by 951

  3. Tricuspid regurgitation is associated with increased mortality independent of pulmonary pressures and right heart failure: a systematic review and meta-analysis

    Authors: Nelson Wang, Jordan Fulcher, Nishan Abeysuriya, Michele McGrady, Ian Wilcox, David S. Celermajer, Sean Lal - European Heart Journal 2018 cited by 399

  4. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery

    Authors: Mary C. Corretti, Todd J. Anderson, Emelia J. Benjamin, David S. Celermajer, François Charbonneau, Mark A. Creager, John Deanfield, Helmut Drexler, Marie Gerhard‐Herman, David M. Herrington, Patrick Vallance, Joseph A. Vita, Robert A. Vogel - Journal of the American College of Cardiology 2002 cited by 4,581

  5. Epidemiology and treatment of pulmonary arterial hypertension

    Authors: Edmund Lau, Eleni Giannoulatou, David S. Celermajer, Marc Humbert - Nature Reviews Cardiology 2017 cited by 503

  6. Poor Long-Term Survival in Patients With Moderate Aortic Stenosis

    Authors: Geoff Strange, Simon Stewart, David S. Celermajer, David L. Prior, G. Scalia, Thomas H. Marwick, Marcus Ilton, Majo Joseph, Jim Codde, David Playford - Journal of the American College of Cardiology 2019 cited by 411

  7. Colchicine Therapy and Plaque Stabilization in Patients With Acute Coronary Syndrome

    Authors: Kaivan Vaidya, Clare Arnott, Gonzalo J. Martínez, Bernard Ng, S. McCormack, David Sullivan, David S. Celermajer, Sanjay Patel - JACC. Cardiovascular imaging 2017 cited by 300

  8. The Assessment of Endothelial Function

    Authors: Andreas J. Flammer, Todd J. Anderson, David S. Celermajer, Mark A. Creager, John Deanfield, Peter Ganz, Naomi M. Hamburg, Thomas F. Lüscher, Michael Shechter, Stefano Taddei, Joseph A. Vita, Amir Lerman - Circulation 2012 cited by 1,135

  9. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis

    Authors: David S. Celermajer, Keld E. Sørensen, Vanda M. Gooch, D. J. Spiegelhalter, O. I. Miller, Ian D. Sullivan, June K. Lloyd, John Deanfield - The Lancet 1992 cited by 4,758

  10. Updated Clinical Classification of Pulmonary Hypertension

    Authors: Gérald Simonneau, Michael Α. Gatzoulis, Ian Adatia, David S. Celermajer, Chris Denton, Hossein Ardeschir Ghofrani, Miguel Ángel Gómez Sánchez, Raman Kumar, Michael J. Landzberg, Roberto F. Machado, Horst Olschewski, Ivan M. Robbins, Rogiero Souza - Journal of the American College of Cardiology 2013 cited by 4,193

  11. The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation

    Authors: Gonzalo J. Martínez, David S. Celermajer, Sanjay Patel - Atherosclerosis 2017 cited by 337

  12. Clinical Pathway for Coronary Atherosclerosis in Patients Without Conventional Modifiable Risk Factors

    Authors: Gemma A. Figtree, Stephen T. Vernon, Jason A. Harmer, Michael P. Gray, Clare Arnott, Eric Bachour, Giannie Barsha, David Brieger, Alex Brown, David S. Celermajer, Keith M. Channon, Nicholas Chew, James J.H. Chong, Clara K Chow, Peter A. Cistulli, Patrick T. Ellinor, Stuart M. Grieve, Tomasz J. Guzik, Emil Hagström, Alicia J. Jenkins, Garry Jennings, Anthony Keech, Katharine A. Kott, Leonard Kritharides, Mamas A. Mamas, Roxana Mehran, Peter J. Meikle, Pradeep Natarajan, Kazuaki Negishi, John O’Sullivan, Sanjay Patel, Peter J. Psaltis, Julie Redfern, Philippe Gabríel Steg, David Sullivan, Johan Sundström, Birgit Vogel, Andrew Wilson, Dennis Wong, Deepak L. Bhatt, Jason C. Kovacic, Stephen J. Nicholls, Zanfina Ademi, Suzanne Avis, Adam S. Chan, Osvaldo Contreras, Craig P. Coorey, S. Fathieh, Elijah Genetzakis, Alireza Gholipour, Corey Giles, Matthew Hollings, Karice Hyun, Samia Kazi, Jason C. Kovacic, Mark Larance, J. Marathe, Clara Marquina, Adam J. Nelson, Hooi Hooi Ng, Ellis Patrick, Karlheinz Peter, Andy Tran, Jean Yang, Dantong Zhu, Clara Zwack - Journal of the American College of Cardiology 2023 cited by 88

  13. Sports-Related Sudden Death in the General Population

    Authors: Éloi Marijon, Muriel Tafflet, David S. Celermajer, Florence Dumas, Marie‐Cécile Perier, Hazrije Mustafić, Jean‐François Toussaint, Michel Desnos, Michel Rieu, Nordine Bénameur, Jean‐Yves Le Heuzey, Jean‐Philippe Empana, Xavier Jouven - Circulation 2011 cited by 538

  14. Kynurenine is an endothelium-derived relaxing factor produced during inflammation

    Authors: Yutang Wang, Hanzhong Liu, Gavin McKenzie, Paul K. Witting, Johannes-Peter Stasch, Michael G. Hahn, Dechaboon Changsirivathanathamrong, Ben J. Wu, Helen J. Ball, Shane R. Thomas, Vimal Kapoor, David S. Celermajer, Andrew L. Mellor, John F. Keaney, Nicholas H. Hunt, Roland Stocker - Nature Medicine 2010 cited by 450

  15. Ejection fraction and mortality: a nationwide register‐based cohort study of 499 153 women and men

    Authors: Simon Stewart, David Playford, G. Scalia, Philip J. Currie, David S. Celermajer, David Prior, Jim Codde, Geoff Strange, on behalf of the NEDA Investigators - European Journal of Heart Failure 2020 cited by 111

  16. Rheumatic heart disease

    Authors: Éloi Marijon, Mariana Mirabel, David S. Celermajer, Xavier Jouven - The Lancet 2012 cited by 850

  17. Cardiovascular Disease in the Developing World

    Authors: David S. Celermajer, Clara K Chow, Éloi Marijon, Nicholas M. Anstey, Kam S. Woo - Journal of the American College of Cardiology 2012 cited by 480

  18. Increasing proportion of ST elevation myocardial infarction patients with coronary atherosclerosis poorly explained by standard modifiable risk factors

    Authors: Stephen T. Vernon, Sean Coffey, Ravinay Bhindi, Soon Yeng Soo Hoo, G. Nelson, Michael R. Ward, Peter S. Hansen, Kaleab Asrress, Clara K Chow, David S. Celermajer, John O’Sullivan, Gemma A. Figtree - European Journal of Preventive Cardiology 2017 cited by 194

  19. Latent Pulmonary Vascular Disease May Alter the Response to Therapeutic Atrial Shunt Device in Heart Failure

    Authors: Barry A. Borlaug, John Blair, Martin W. Bergmann, Heiko Bugger, Dan Burkhoff, Leonhard Bruch, David S. Celermajer, Brian Claggett, John G.F. Cleland, Donald E. Cutlip, Ira Dauber, Jean-Christophe Eicher, Qi Gao, Thomas M. Gorter, Finn Gustafsson, Chris Hayward, Jan van der Heyden, Gerd Hasenfuß, Scott L. Hummel, David M. Kaye, Jan Komtebedde, Joseph M. Massaro, Jeremy A. Mazurek, Scott McKenzie, Shamir R. Mehta, Mark C. Petrie, Marco C. Post, Ajith Nair, Andreas Rieth, Frank E. Silvestry, Scott D. Solomon, Jean-Noël Trochu, Dirk J. Van Veldhuisen, Ralf Westenfeld, Martin B. Leon, Sanjiv J. Shah, on behalf of the REDUCE LAP-HF-II Investigators - Circulation 2022 cited by 120

  20. Adverse Prognostic Impact of Even Mild or Moderate Tricuspid Regurgitation: Insights from the National Echocardiography Database of Australia

    Authors: Sophie Offen, David Playford, Geoff Strange, Simon Stewart, David S. Celermajer - Journal of the American Society of Echocardiography 2022 cited by 107

  21. Diastolic dysfunction and mortality in 436 360 men and women: the National Echo Database Australia (NEDA)

    Authors: David Playford, Geoff Strange, David S. Celermajer, Geoffrey Evans, G. Scalia, Simon Stewart, David Prior, the NEDA Investigators - European Heart Journal - Cardiovascular Imaging 2020 cited by 129

  22. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women

    Authors: David S. Celermajer, Keld E. Sørensen, D Spiegelhalter, Dimitri Georgakopoulos, J. Robinson, John Deanfield - Journal of the American College of Cardiology 1994 cited by 1,328

  23. Colchicine Acutely Suppresses Local Cardiac Production of Inflammatory Cytokines in Patients With an Acute Coronary Syndrome

    Authors: Gonzalo J. Martínez, S. E. J. Robertson, Jennifer Barraclough, Qiong Xia, Ziad Mallat, Christina A. Bursill, David S. Celermajer, Sanjay Patel - Journal of the American Heart Association 2015 cited by 281

  24. Colchicine therapy in acute coronary syndrome patients acts on caspase-1 to suppress NLRP3 inflammasome monocyte activation

    Authors: S. E. J. Robertson, Gonzalo J. Martínez, Cloé Payet, Jennifer Barraclough, David S. Celermajer, Christina A. Bursill, Sanjay Patel - Clinical Science 2016 cited by 159